2013 Q4 Form 10-Q Financial Statement

#000119312513425215 Filed on November 04, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $0.00
YoY Change
Cost Of Revenue $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $2.150M $2.158M $1.790M
YoY Change 20.11% 18.84% -1.1%
% of Gross Profit
Research & Development $3.520M $3.102M $2.110M
YoY Change 66.82% 87.12% 20.57%
% of Gross Profit
Depreciation & Amortization $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
% of Gross Profit
Operating Expenses $5.680M $5.271M $3.910M
YoY Change 45.27% 63.76% 9.52%
Operating Profit -$5.722M -$5.271M -$4.016M
YoY Change 42.47% 63.76%
Interest Expense $20.00K $20.00K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$137.00 $0.00
YoY Change -112.47% -100.0%
Pretax Income -$5.700M -$5.250M -$4.000M
YoY Change 42.5% 64.06% 68.78%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.705M -$5.254M -$3.997M
YoY Change 42.73% 64.22% 68.64%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.878M -$3.571M -$5.882M
COMMON SHARES
Basic Shares Outstanding 102.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.40M $49.40M $36.50M
YoY Change 21.64% 23.81% -28.01%
Cash & Equivalents $25.68M $30.23M $22.50M
Short-Term Investments $18.70M $19.10M $14.00M
Other Short-Term Assets $1.100M $500.0K $700.0K
YoY Change 57.14% -70.59% -36.36%
Inventory
Prepaid Expenses $542.4K $646.6K
Receivables
Other Receivables
Total Short-Term Assets $45.53M $49.93M $37.17M
YoY Change 22.47% 20.03% -28.23%
LONG-TERM ASSETS
Property, Plant & Equipment $106.0K $115.1K $198.4K
YoY Change -46.56% -61.64% -57.29%
Goodwill $3.007M $3.007M $3.007M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $60.00K $43.91K $43.91K
YoY Change 36.64% -99.33% 0.0%
Total Long-Term Assets $9.722M $9.715M $9.798M
YoY Change -0.78% -2.85% -2.64%
TOTAL ASSETS
Total Short-Term Assets $45.53M $49.93M $37.17M
Total Long-Term Assets $9.722M $9.715M $9.798M
Total Assets $55.25M $59.65M $46.97M
YoY Change 17.62% 15.6% -24.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $964.0K $794.7K $698.8K
YoY Change 37.94% 164.89% 54.71%
Accrued Expenses $2.495M $2.155M $1.284M
YoY Change 94.32% 2.63% 14.6%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.833M $3.977M $2.571M
YoY Change 88.01% 47.29% 4.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.833M $3.977M $2.571M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $7.442M $6.585M $5.179M
YoY Change 43.68% 24.25% 2.0%
SHAREHOLDERS EQUITY
Retained Earnings -$206.4M
YoY Change
Common Stock $254.3M $253.8M $226.7M
YoY Change 12.13% 0.25%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.454K
YoY Change
Treasury Stock Shares 0.000 shares 1.454M shares
Shareholders Equity $47.81M $53.06M $41.79M
YoY Change
Total Liabilities & Shareholders Equity $55.25M $59.65M $46.97M
YoY Change 17.62% 15.6% -24.06%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$5.705M -$5.254M -$3.997M
YoY Change 42.73% 64.22% 68.64%
Depreciation, Depletion And Amortization $10.00K $10.00K $10.00K
YoY Change 0.0% 0.0% 0.0%
Cash From Operating Activities -$4.860M -$3.770M -$3.350M
YoY Change 45.07% 18.93% 10.93%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K -$60.00K
YoY Change -100.0% -70.0%
Acquisitions
YoY Change
Other Investing Activities $430.0K -$10.70M -$200.0K
YoY Change -315.0% 1428.57% -87.65%
Cash From Investing Activities $420.0K -$10.73M -$260.0K
YoY Change -261.54% 1432.86% -85.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -110.0K -250.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -4.860M -3.770M -3.350M
Cash From Investing Activities 420.0K -10.73M -260.0K
Cash From Financing Activities -110.0K -250.0K 0.000
Net Change In Cash -4.550M -14.75M -3.610M
YoY Change 26.04% 281.14% -133.43%
FREE CASH FLOW
Cash From Operating Activities -$4.860M -$3.770M -$3.350M
Capital Expenditures $0.00 -$30.00K -$60.00K
Free Cash Flow -$4.860M -$3.740M -$3.290M
YoY Change 47.72% 17.98% 16.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
102710286 shares
CY2011Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
6700000
CY1996Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
CY2013Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
0.5 shares
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26088710
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
102710286 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
44585932 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
102710286 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.41
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7148103 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2155179
CY2013Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
325944
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
794674
CY2013Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
2600000
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3976741
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-28722
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1026888
CY2013Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
53063769
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
253713892
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
102710
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59649265
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2608755
CY2013Q3 us-gaap Liabilities
Liabilities
6585496
CY2013Q3 us-gaap Assets Current
AssetsCurrent
49934378
CY2013Q3 us-gaap Goodwill
Goodwill
3006883
CY2013Q3 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
2500000
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43912
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
542423
CY2013Q3 us-gaap Assets
Assets
59649265
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30231154
CY2013Q3 us-gaap Nontrade Receivables
NontradeReceivables
29185
CY2013Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
19158030
CY2013Q3 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
200724111
CY2013Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
19131616
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3000000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
115092
CY2013Q3 mstx In Process Research And Development
InProcessResearchAndDevelopment
6549000
CY2013Q3 mstx Accrued Contracts And Study Expenses
AccruedContractsAndStudyExpenses
1829235
CY2013Q3 mstx Contingent Liability
ContingentLiability
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43569947
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46265286 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47719365 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.31
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3585743 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1454079 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1283976
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80168
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
698838
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2570666
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2194
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
445352
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
142500
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
41792394
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
226696863
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
47720
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
46971815
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2608755
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43912
CY2012Q4 us-gaap Liabilities
Liabilities
5179421
CY2012Q4 us-gaap Assets Current
AssetsCurrent
37173662
CY2012Q4 us-gaap Goodwill
Goodwill
3006883
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
646571
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
184948541
CY2012Q4 us-gaap Nontrade Receivables
NontradeReceivables
15689
CY2012Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
14010962
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1454
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
198358
CY2012Q4 us-gaap Assets
Assets
46971815
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22500440
CY2012Q4 mstx In Process Research And Development
InProcessResearchAndDevelopment
6549000
CY2012Q4 mstx Accrued Contracts And Study Expenses
AccruedContractsAndStudyExpenses
1203808
CY2012Q4 mstx Contingent Liability
ContingentLiability
142500
CY2011Q2 mstx Number Of Primary Endpoints Patients
NumberOfPrimaryEndpointsPatients
Exceeds 250 patients
CY2011Q2 mstx Probability Of Obtaining Test Statistic Significance Level Stated Description
ProbabilityOfObtainingTestStatisticSignificanceLevelStatedDescription
With a p value of 0.01 in the primary endpoint shall not exceeds 250 (unless otherwise agreed)
dei Entity Registrant Name
EntityRegistrantName
Mast Therapeutics, Inc.
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0001160308
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25853289
us-gaap Dividends Preferred Stock
DividendsPreferredStock
us-gaap Cost Of Goods Sold
CostOfGoodsSold
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.74
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67781879 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.51
us-gaap Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued
BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
250000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12928675
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>10. Recent Accounting Pronouncements</b></p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> In July 2013, the Financial Accounting Standards Board (&#x201C;FASB&#x201D;) issued ASU No.&#xA0;2013-11, <i>Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists</i> (&#x201C;ASU 2013-11&#x201D;). This standard requires an unrecognized tax benefit related to a net operating loss carryforward, a similar tax loss or a tax credit carryforward to be presented as a reduction to a deferred tax asset, unless the tax benefit is not available at the reporting date to settle any additional income taxes under the tax law of the applicable tax jurisdiction. ASU 2013-11 is effective for fiscal years and interim periods beginning after December&#xA0;15, 2013, with early adoption permitted. We do not believe that the adoption of this standard will have an impact on our consolidated financial position, results of operations or cash flows.</p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> In February 2013, FASB issued ASU No.&#xA0;2013-02, <i>Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income</i> (&#x201C;ASU 2013-02&#x201D;). This standard requires companies to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, companies are required to present, either on the face of the statement where net income is presented or in the accompanying notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income, but only if the amount reclassified is required to be reclassified to net income in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, companies are required to cross-reference to other disclosures that provide additional detail on those amounts. ASU 2013-02 is effective prospectively for reporting periods beginning after December&#xA0;15, 2012. We adopted this guidance effective January&#xA0;1, 2013. Our adoption of this standard did not have a significant impact on our consolidated financial position, results of operations and other comprehensive income/loss or cash flows. There were no realized gains or losses on marketable securities in the three months ended September&#xA0;30, 2013.</p> <p style="MARGIN-TOP: 6pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; MARGIN-LEFT: 4%; FONT-SIZE: 10pt"> In December 2011, FASB issued ASU 2011-11, <i>Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities</i> (&#x201C;ASU 2011-11&#x201D;). ASU 2011-11 requires companies to provide new disclosures about offsetting and related arrangements for financial instruments and derivatives. The provisions of ASU&#xA0;2011-11 are effective for annual reporting periods beginning on or after January&#xA0;1, 2013, and must be applied retrospectively. We adopted this guidance effective January&#xA0;1, 2013. The adoption of this standard did not have a significant impact on our consolidated financial position, results of operations and other comprehensive income/loss or cash flows.</p> </div>
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3765504 shares
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
203144 shares
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1335
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
26528
us-gaap Licenses Revenue
LicensesRevenue
us-gaap Gross Profit
GrossProfit
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-26414
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15775570
us-gaap Revenues
Revenues
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-90500
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15802098
us-gaap Investment Income Interest
InvestmentIncomeInterest
42638
us-gaap Profit Loss
ProfitLoss
-15775570
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
99875
us-gaap Revenue From Grants
RevenueFromGrants
us-gaap Operating Income Loss
OperatingIncomeLoss
-15816873
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
us-gaap Interest Paid
InterestPaid
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2244211
us-gaap Net Income Loss
NetIncomeLoss
-15775570
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-26528
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-35000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45348
us-gaap Payments Of Dividends
PaymentsOfDividends
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
18300000
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
us-gaap Share Based Compensation
ShareBasedCompensation
1159021
us-gaap Depreciation And Amortization
DepreciationAndAmortization
28738
mstx Cash Transferred In Rescission Of Acquisition
CashTransferredInRescissionOfAcquisition
mstx Forgiveness Of Employee Receivable
ForgivenessOfEmployeeReceivable
mstx Trade Asset Converted To Available For Sale Asset
TradeAssetConvertedToAvailableForSaleAsset
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1159021
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1533636
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
28100000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
177500
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
us-gaap Operating Expenses
OperatingExpenses
15816873
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7730714
us-gaap Interest Expense
InterestExpense
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28097500
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9382087
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6371048
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1522
mstx Expenses Paid By Issuance Of Common Stock
ExpensesPaidByIssuanceOfCommonStock
mstx Cash Received In Rescission Of Acquisition
CashReceivedInRescissionOfAcquisition
mstx Transaction Related Expenses
TransactionRelatedExpenses
-35000
mstx Dividends Extinguished
DividendsExtinguished
mstx Dividends Accrued
DividendsAccrued
mstx Prepaid Services To Consultants
PrepaidServicesToConsultants
mstx Gain Loss On Change In Fair Value Of Contingent Consideration
GainLossOnChangeInFairValueOfContingentConsideration
-35000
mstx Acquisition Of Treasury Stock In Settlement Of Claim
AcquisitionOfTreasuryStockInSettlementOfClaim
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
25700000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5192378
mstx Trade Payable Converted To Note Payable
TradePayableConvertedToNotePayable
mstx Fair Value Of Contingent Liabilities Net Of Contingent Assets
FairValueOfContingentLiabilitiesNetOfContingentAssets
mstx Underwriter Commissions In Conjunction With Financings
UnderwriterCommissionsInConjunctionWithFinancings
mstx Proceeds From Issuance Of Notes Payable And Detachable Warrants
ProceedsFromIssuanceOfNotesPayableAndDetachableWarrants
mstx Financial Advisor Services In Connection With Private Placements
FinancialAdvisorServicesInConnectionWithPrivatePlacements
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28738
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
210909
mstx Fair Value Of Common Stock Issued For Milestone
FairValueOfCommonStockIssuedForMilestone
250
mstx Payments For Repurchase Of Vesting Shares
PaymentsForRepurchaseOfVestingShares
mstx Advance To Investee
AdvanceToInvestee
mstx Write Off Of License Agreement
WriteOffOfLicenseAgreement
mstx Purchase Of Certificate Of Deposits
PurchaseOfCertificateOfDeposits
19407030
mstx Acquisition Of License Agreement For Long Term Debt
AcquisitionOfLicenseAgreementForLongTermDebt
mstx Expenses Paid By Issuance Of Warrants
ExpensesPaidByIssuanceOfWarrants
mstx New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets One
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssetsOne
mstx Detachable Warrants Issued With Notes Payable
DetachableWarrantsIssuedWithNotesPayable
mstx Proceeds From Sale Of Certificate Of Deposit
ProceedsFromSaleOfCertificateOfDeposit
mstx Maturity Of Certificate Of Deposits
MaturityOfCertificateOfDeposits
14260000
mstx Stock Issued During Period Value Warrants Exercised Cashless
StockIssuedDuringPeriodValueWarrantsExercisedCashless
mstx Finance Costs Included In Accounts Payable And Accrued Liabilities
FinanceCostsIncludedInAccountsPayableAndAccruedLiabilities
116336
mstx Purchase Of Property And Equipment In Accounts Payable
PurchaseOfPropertyAndEquipmentInAccountsPayable
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10569328
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
us-gaap Revenues
Revenues
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
437266
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11562654
us-gaap Gross Profit
GrossProfit
mstx Conversion Of Preferred Shares
ConversionOfPreferredShares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47715709 shares
mstx Cash Transferred In Rescission Of Acquisition
CashTransferredInRescissionOfAcquisition
mstx Forgiveness Of Employee Receivable
ForgivenessOfEmployeeReceivable
mstx Trade Asset Converted To Available For Sale Asset
TradeAssetConvertedToAvailableForSaleAsset
mstx Expense Related To Stock Options Issued To Non Employees
ExpenseRelatedToStockOptionsIssuedToNonEmployees
mstx Cash Paid In Lieu For Reverse Stock Split
CashPaidInLieuForReverseStockSplit
mstx Expenses Related To Stock Warrants Issued
ExpensesRelatedToStockWarrantsIssued
mstx Description Of Fixed Combination Of Shares And Warrant Offered And Sold To Public
DescriptionOfFixedCombinationOfSharesAndWarrantOfferedAndSoldToPublic
Securities were offered and sold to the underwriters and the public in units with each unit consisting of one share of common stock and one warrant to purchase up to 0.5 of a share of common stock.
mstx Expenses Paid By Issuance Of Preferred Stock
ExpensesPaidByIssuanceOfPreferredStock
mstx Conversion Of Notes Payable And Accrued Interest
ConversionOfNotesPayableAndAccruedInterest
mstx Net Cash Settlement Provision
NetCashSettlementProvision
0
mstx Cumulative Preferred Stock Dividends
CumulativePreferredStockDividends
mstx Class Of Warrant Or Rights Date Up To Which Warrants Or Rights Exercisable
ClassOfWarrantOrRightsDateUpToWhichWarrantsOrRightsExercisable
2018-06-19
mstx Payment On Obligation Under License Agreement
PaymentOnObligationUnderLicenseAgreement
mstx Issuance Of Warrants For Return Of Common Stock
IssuanceOfWarrantsForReturnOfCommonStock
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-4503
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11562733
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7480
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-79
us-gaap Licenses Revenue
LicensesRevenue
us-gaap Investment Income Interest
InvestmentIncomeInterest
56300
us-gaap Profit Loss
ProfitLoss
-11562733
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
us-gaap Revenue From Grants
RevenueFromGrants
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
127484
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
300114
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
us-gaap Operating Income Loss
OperatingIncomeLoss
-11611553
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
us-gaap Interest Paid
InterestPaid
us-gaap Payments Of Dividends
PaymentsOfDividends
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
us-gaap Net Income Loss
NetIncomeLoss
-11562733
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-21840
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
79
us-gaap Operating Expenses
OperatingExpenses
11611553
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5732478
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
mstx Expenses Paid By Issuance Of Common Stock
ExpensesPaidByIssuanceOfCommonStock
mstx Cash Received In Rescission Of Acquisition
CashReceivedInRescissionOfAcquisition
mstx Transaction Related Expenses
TransactionRelatedExpenses
174711
mstx Dividends Extinguished
DividendsExtinguished
mstx Dividends Accrued
DividendsAccrued
mstx Prepaid Services To Consultants
PrepaidServicesToConsultants
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6911909
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
77569
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1073872
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
us-gaap Dividends Preferred Stock
DividendsPreferredStock
us-gaap Cost Of Goods Sold
CostOfGoodsSold
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
us-gaap Share Based Compensation
ShareBasedCompensation
1073872
us-gaap Depreciation And Amortization
DepreciationAndAmortization
77569
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17481237
us-gaap Interest Expense
InterestExpense
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
5976217
mstx Gain Loss On Change In Fair Value Of Contingent Consideration
GainLossOnChangeInFairValueOfContingentConsideration
174711
mstx Acquisition Of Treasury Stock In Settlement Of Claim
AcquisitionOfTreasuryStockInSettlementOfClaim
mstx Trade Payable Converted To Note Payable
TradePayableConvertedToNotePayable
mstx Fair Value Of Contingent Liabilities Net Of Contingent Assets
FairValueOfContingentLiabilitiesNetOfContingentAssets
mstx Underwriter Commissions In Conjunction With Financings
UnderwriterCommissionsInConjunctionWithFinancings
mstx Proceeds From Issuance Of Notes Payable And Detachable Warrants
ProceedsFromIssuanceOfNotesPayableAndDetachableWarrants
mstx Financial Advisor Services In Connection With Private Placements
FinancialAdvisorServicesInConnectionWithPrivatePlacements
mstx Fair Value Of Common Stock Issued For Milestone
FairValueOfCommonStockIssuedForMilestone
mstx Payments For Repurchase Of Vesting Shares
PaymentsForRepurchaseOfVestingShares
mstx Advance To Investee
AdvanceToInvestee
mstx Write Off Of License Agreement
WriteOffOfLicenseAgreement
mstx Purchase Of Certificate Of Deposits
PurchaseOfCertificateOfDeposits
13581000
mstx Acquisition Of License Agreement For Long Term Debt
AcquisitionOfLicenseAgreementForLongTermDebt
mstx Expenses Paid By Issuance Of Warrants
ExpensesPaidByIssuanceOfWarrants
mstx New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets One
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssetsOne
mstx Detachable Warrants Issued With Notes Payable
DetachableWarrantsIssuedWithNotesPayable
mstx Expense Related To Stock Options Issued To Non Employees
ExpenseRelatedToStockOptionsIssuedToNonEmployees
mstx Cash Paid In Lieu For Reverse Stock Split
CashPaidInLieuForReverseStockSplit
mstx Expenses Related To Stock Warrants Issued
ExpensesRelatedToStockWarrantsIssued
mstx Expenses Paid By Issuance Of Preferred Stock
ExpensesPaidByIssuanceOfPreferredStock
mstx Conversion Of Notes Payable And Accrued Interest
ConversionOfNotesPayableAndAccruedInterest
mstx Cumulative Preferred Stock Dividends
CumulativePreferredStockDividends
mstx Payment On Obligation Under License Agreement
PaymentOnObligationUnderLicenseAgreement
mstx Issuance Of Warrants For Return Of Common Stock
IssuanceOfWarrantsForReturnOfCommonStock
mstx Proceeds From Sale Of Certificate Of Deposit
ProceedsFromSaleOfCertificateOfDeposit
mstx Maturity Of Certificate Of Deposits
MaturityOfCertificateOfDeposits
6880000
mstx Stock Issued During Period Value Warrants Exercised Cashless
StockIssuedDuringPeriodValueWarrantsExercisedCashless
mstx Finance Costs Included In Accounts Payable And Accrued Liabilities
FinanceCostsIncludedInAccountsPayableAndAccruedLiabilities
mstx Purchase Of Property And Equipment In Accounts Payable
PurchaseOfPropertyAndEquipmentInAccountsPayable
mstx Conversion Of Preferred Shares
ConversionOfPreferredShares
CY2013Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
99875
CY2013Q2 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1454079 shares
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
56195000 shares
CY2013Q2 mstx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Underwriter
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToUnderwriter
28097500 shares
CY2011Q2 mstx Probability Of Obtaining Test Statistic P Value
ProbabilityOfObtainingTestStatisticPValue
0.01 PValue
CY2012 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
400000
CY2012 mstx Repurchase Of Common Shares Subject To Vesting
RepurchaseOfCommonSharesSubjectToVesting
1454079 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-147094797
us-gaap Revenues
Revenues
2093522
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
865359
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-202981440
us-gaap Gross Profit
GrossProfit
2042428
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
111183884
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-61315
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
55279
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-214080641
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
128370
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
605909
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
26566
us-gaap Licenses Revenue
LicensesRevenue
1300000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4874846
us-gaap Profit Loss
ProfitLoss
-202926897
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
35000
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
99875
us-gaap Revenue From Grants
RevenueFromGrants
618692
us-gaap Operating Income Loss
OperatingIncomeLoss
-195498696
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
174830
us-gaap Interest Paid
InterestPaid
180719
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
16141578
us-gaap Net Income Loss
NetIncomeLoss
-202952718
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1571502
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28722
us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1531806
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-178936
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1782152
us-gaap Payments Of Dividends
PaymentsOfDividends
213000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3828814
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
510739
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
12239688
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
30666878
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
196200262
us-gaap Dividends Preferred Stock
DividendsPreferredStock
621240
us-gaap Cost Of Goods Sold
CostOfGoodsSold
51094
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
32395
us-gaap Share Based Compensation
ShareBasedCompensation
12708345
us-gaap Depreciation And Amortization
DepreciationAndAmortization
11053973
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
30231154
us-gaap Interest Expense
InterestExpense
191729
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
151756371
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
66920
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
95439543
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18884429
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
14714258
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
714561
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10603975
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
10506683
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
10422130
us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
405993
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
5702130
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
113036378
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
44474720
us-gaap Operating Expenses
OperatingExpenses
197541124
us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
34737
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
450000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74037760
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
10118
mstx Expenses Paid By Issuance Of Common Stock
ExpensesPaidByIssuanceOfCommonStock
1341372
mstx Cash Received In Rescission Of Acquisition
CashReceivedInRescissionOfAcquisition
230000
mstx Transaction Related Expenses
TransactionRelatedExpenses
-706652
mstx Dividends Extinguished
DividendsExtinguished
408240
mstx Dividends Accrued
DividendsAccrued
621040
mstx Prepaid Services To Consultants
PrepaidServicesToConsultants
1482781
mstx Gain Loss On Change In Fair Value Of Contingent Consideration
GainLossOnChangeInFairValueOfContingentConsideration
1493907
mstx Acquisition Of Treasury Stock In Settlement Of Claim
AcquisitionOfTreasuryStockInSettlementOfClaim
34737
mstx Trade Payable Converted To Note Payable
TradePayableConvertedToNotePayable
83948
mstx Fair Value Of Contingent Liabilities Net Of Contingent Assets
FairValueOfContingentLiabilitiesNetOfContingentAssets
784419
mstx Underwriter Commissions In Conjunction With Financings
UnderwriterCommissionsInConjunctionWithFinancings
766784
mstx Proceeds From Issuance Of Notes Payable And Detachable Warrants
ProceedsFromIssuanceOfNotesPayableAndDetachableWarrants
1344718
mstx Financial Advisor Services In Connection With Private Placements
FinancialAdvisorServicesInConnectionWithPrivatePlacements
3477571
mstx Fair Value Of Common Stock Issued For Milestone
FairValueOfCommonStockIssuedForMilestone
250
mstx Payments For Repurchase Of Vesting Shares
PaymentsForRepurchaseOfVestingShares
1454
mstx Advance To Investee
AdvanceToInvestee
90475
mstx Write Off Of License Agreement
WriteOffOfLicenseAgreement
-152866
mstx Purchase Of Certificate Of Deposits
PurchaseOfCertificateOfDeposits
43390209
mstx Acquisition Of License Agreement For Long Term Debt
AcquisitionOfLicenseAgreementForLongTermDebt
161180
mstx Expenses Paid By Issuance Of Warrants
ExpensesPaidByIssuanceOfWarrants
573357
mstx New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets One
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssetsOne
-25821
mstx Detachable Warrants Issued With Notes Payable
DetachableWarrantsIssuedWithNotesPayable
450000
mstx Cash Transferred In Rescission Of Acquisition
CashTransferredInRescissionOfAcquisition
19475
mstx Forgiveness Of Employee Receivable
ForgivenessOfEmployeeReceivable
-30036
mstx Trade Asset Converted To Available For Sale Asset
TradeAssetConvertedToAvailableForSaleAsset
108000
mstx Expense Related To Stock Options Issued To Non Employees
ExpenseRelatedToStockOptionsIssuedToNonEmployees
204664
mstx Cash Paid In Lieu For Reverse Stock Split
CashPaidInLieuForReverseStockSplit
146
mstx Expenses Related To Stock Warrants Issued
ExpensesRelatedToStockWarrantsIssued
-612000
mstx Expenses Paid By Issuance Of Preferred Stock
ExpensesPaidByIssuanceOfPreferredStock
142501
mstx Conversion Of Notes Payable And Accrued Interest
ConversionOfNotesPayableAndAccruedInterest
1213988
mstx Cumulative Preferred Stock Dividends
CumulativePreferredStockDividends
13502403
mstx Payment On Obligation Under License Agreement
PaymentOnObligationUnderLicenseAgreement
106250
mstx Issuance Of Warrants For Return Of Common Stock
IssuanceOfWarrantsForReturnOfCommonStock
50852
mstx Proceeds From Sale Of Certificate Of Deposit
ProceedsFromSaleOfCertificateOfDeposit
248000
mstx Maturity Of Certificate Of Deposits
MaturityOfCertificateOfDeposits
23703330
mstx Stock Issued During Period Value Warrants Exercised Cashless
StockIssuedDuringPeriodValueWarrantsExercisedCashless
4312
mstx Finance Costs Included In Accounts Payable And Accrued Liabilities
FinanceCostsIncludedInAccountsPayableAndAccruedLiabilities
116336
mstx Purchase Of Property And Equipment In Accounts Payable
PurchaseOfPropertyAndEquipmentInAccountsPayable
22966
mstx Conversion Of Preferred Shares
ConversionOfPreferredShares
13674
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47715709 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2012Q3 us-gaap Revenues
Revenues
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3198977
CY2012Q3 us-gaap Gross Profit
GrossProfit
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3199053
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1099
CY2012Q3 us-gaap Licenses Revenue
LicensesRevenue
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
18347
CY2012Q3 us-gaap Profit Loss
ProfitLoss
-3199053
CY2012Q3 us-gaap Revenue From Grants
RevenueFromGrants
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3218499
CY2012Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-3199053
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
76
CY2012Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2012Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2012Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2012Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10638
CY2012Q3 us-gaap Interest Expense
InterestExpense
CY2012Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1657902
CY2012Q3 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
CY2012Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
CY2012Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
359543
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
3218499
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1816181
CY2012Q3 mstx Transaction Related Expenses
TransactionRelatedExpenses
266222
CY2012Q3 mstx New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets One
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssetsOne
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
102710286 shares
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2013Q3 us-gaap Revenues
Revenues
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5273415
CY2013Q3 us-gaap Gross Profit
GrossProfit
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5253531
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-137
CY2013Q3 us-gaap Licenses Revenue
LicensesRevenue
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
17327
CY2013Q3 us-gaap Profit Loss
ProfitLoss
-5253531
CY2013Q3 us-gaap Revenue From Grants
RevenueFromGrants
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5270721
CY2013Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-5253531
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19884
CY2013Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2013Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
CY2013Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10064
CY2013Q3 us-gaap Interest Expense
InterestExpense
CY2013Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3102240
CY2013Q3 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
CY2013Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
CY2013Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
442328
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
5270721
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2158417
CY2013Q3 mstx Transaction Related Expenses
TransactionRelatedExpenses
CY2013Q3 mstx New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets One
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssetsOne

Files In Submission

Name View Source Status
0001193125-13-425215-index-headers.html Edgar Link pending
0001193125-13-425215-index.html Edgar Link pending
0001193125-13-425215.txt Edgar Link pending
0001193125-13-425215-xbrl.zip Edgar Link pending
d614793d10q.htm Edgar Link pending
d614793dex311.htm Edgar Link pending
d614793dex312.htm Edgar Link pending
d614793dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mstx-20130930.xml Edgar Link completed
mstx-20130930.xsd Edgar Link pending
mstx-20130930_cal.xml Edgar Link unprocessable
mstx-20130930_def.xml Edgar Link unprocessable
mstx-20130930_lab.xml Edgar Link unprocessable
mstx-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending